BA
TXMD icon

BlackRock Advisors’s TherapeuticsMD TXMD Stock Holding History

BlackRock Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$472K Buy
1,637
+28
+2% +$8.68K ﹤0.01% 2242
2016
Q3 		$548K Buy
1,609
+205
+15% +$74.9K ﹤0.01% 2129
2016
Q2 		$597K Buy
1,404
+78
+6% +$32.1K ﹤0.01% 2024
2016
Q1 		$424K Sell
1,326
-1,250
-49% -$426K ﹤0.01% 2163
2015
Q4 		$1.34M Sell
2,576
-935
-27% -$345K ﹤0.01% 1585
2015
Q3 		$1.03M Buy
3,511
+254
+8% +$90.3K ﹤0.01% 1673
2015
Q2 		$1.28M Buy
3,257
+1,812
+125% +$639K ﹤0.01% 1500
2015
Q1 		$437K Buy
1,445
+312
+28% +$76.2K ﹤0.01% 2175
2014
Q4 		$252K Sell
1,133
-59
-5% -$12.2K ﹤0.01% 2477
2014
Q3 		$277K Buy
1,192
+339
+40% +$85.4K ﹤0.01% 2400
2014
Q2 		$189K Sell
853
-47
-5% -$10.5K ﹤0.01% 2671
2014
Q1 		$284K Buy
900
+42
+5% +$13.4K ﹤0.01% 2443
2013
Q4 		$224K Buy
858
+136
+19% +$29.8K ﹤0.01% 2591
2013
Q3 		$106K Buy
722
+16
+2% +$1.94K ﹤0.01% 2929
2013
Q2 		$107K Buy
+706
New +$96.7K ﹤0.01% 2854

Other funds holding TXMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Advisors's TXMD Position: Q4 2016 in Review

BlackRock Advisors increased its TherapeuticsMD (TXMD) stake by 1.7% in Q4 2016, buying an estimated $8.68K and bringing the position to 1,637 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #2242.

BlackRock Advisors first reported a position in TXMD in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.34M in Q4 2015. 146 funds tracked by Wall St. Rank hold TXMD as of Q4 2016.

  • BlackRock Advisors held 1,637 shares of TherapeuticsMD worth $472K as of Q4 2016.
  • BlackRock Advisors bought 28 TherapeuticsMD shares in Q4 2016, an estimated $8.68K.
  • TherapeuticsMD made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2242 holding.
  • BlackRock Advisors first reported a position in TherapeuticsMD in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's TherapeuticsMD position peaked at $1.34M in Q4 2015.
  • 146 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.